8th Annual DigIT Pharma & eHealth Conference - Commercial Excellence is organized by International Quality and Productivity Center (IQPC) and will be held from Sep 10 - 11, 2024 at Hilton Dusseldorf, Dusseldorf, North Rhine-Westphalia, Germany.
Key topics 2024:
• Commercial Excellence, Marketing & Sales : Sales Effectiveness with next best action and real-time support in face2face conversations - Hyper personalized marketing and sales - Personalized marketing content creation with GenAI and data for highly personalized output
• Scaling Omni Channel : Data-based orchestration and personalization of the Omni Channel: Continuous and sustainable integration and scaling at all levels, sales effectiveness, personalized approach, content strategies, customer journeys
• Market Access : Real World Data & Real World Evidence, Insights for Patient Outcomes
• New Digital Channels and Platforms : Technologies for automation and efficiency improvement (Generative AI, Next Best Action, etc.)
• Data & Data-driven Approaches : Analytics dashboards, data-driven decisions in targeting and content strategy, use of synthetic data. Innovative approaches to compiling diverse and representative data sets.
• Mindset and Change : Motivation for digital and data-driven thinking in field service, Data & AI Literacy
• Improve Communication With HCP : CX transformation, understanding physicians’ needs, synergies with Medical Affairs, new communication tools
• Medical Technology Marketing & Sales : What can the pharmaceutical industry learn from Medtech?
• Generative AI: Insights into commercial excellence business cases with Generative AI to increase productivity and reduce costs; formation of Generative AI strategies & models, change management - collaboration AI - bot - human; reskilling and upskilling
• Goodby Writing - Hello Prompting: Learn the art of prompt engineering to get more accurate and better results with Gen AI. How to use ChatGPT and other large language models to build reliable systems?
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved